Ali Yılmaz
9PUBLICATIONS
9CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (9)
Sort by Publication Date:
|May 31, 2024
Inflammatory parameters in NSCLC with driver mutation.Mehmet Emin Buyukbayram, Zekeriya Hannarici, Ali Yilmaz
|May 01, 2023
The value of pretreatment glucose-to-lymphocyte ratio for predicting survival of metastatic gastric cancer.Zekeriya Hannarici, Ali Yılmaz, Mehmet Emin Buyukbayram
|Feb 24, 2022
Lipegfilgrastim may cause hyperleukocytosis.Zekeriya Hannarici, Ali Yılmaz, Mehmet Emin Buyukbayram
|Aug 25, 2021
The importance of the glucose-to-lymphocyte ratio in patients with hepatocellular carcinoma treated with sorafenib.Ali Yılmaz, Melih Şimşek, Zekeriya Hannarici
|Aug 12, 2021
Prognostic significance of hemoglobin-to-red cell distribution width ratio in patients with metastatic renal cancer.Hatice Yılmaz, Ali Yılmaz, Güzin Demirağ
|Jul 11, 2020
The prognostic significance of hemoglobin-to-red cell distribution width ratio in muscle-invasive bladder cancer.Ali Yılmaz, Hatice Yılmaz, Salim Başol Tekin
Pageof 2
Frequent Collaborators
4 joint publications
Zekeriya Hannarici
2 joint publications
Hatice Yılmaz
1 joint publications
Mehmet Emin Buyukbayram
1 joint publications
Aykut Turhan
1 joint publications
Alperen Akansel Caglar
1 joint publications
Pınar Coban Esdur
1 joint publications
Mehmet Bilici
1 joint publications
Salim Basol Tekin
1 joint publications
Melih Şimşek
